(18.117.183.252)
Users online: 18650     
Ijournet
Email id
 

Indian Journal of Clinical and Experimental Dermatology
Year : 2015, Volume : 1, Issue : 1
First page : ( 14) Last page : ( 16)

Does isotretinoin (ISO) Therapy Increase Coagulation Tendency? Evaluation of MPV values and MPV/platelet rate

Ozuguz Pinar1,*, Ulu M. Sena2, Kacar Seval Dogruk1, Ozuguz Ufuk3, Karaca Semsettin1

1Department of Dermatology, Izmir Katip Celebi University, Turkey

2Department of Nephrology, Afyon Kocatepe University, Turkey

3Department of Endocrinology, Afyon Kocatepe University, Turkey

*Corresponding Author: Email: pozoguz@gmail.com

Online published on 3 March, 2016.

Abstract

Introduction/Purpose

Mean Platelet Volume (MPV), an indicator of platelet activation, is a new risk factor for atherothrombosis and an important marker for the increase in thromboembolic diseases. MPV/platelet ratio is considered as a risk factor for various diseases such as myocardial infarction. In this study, we aimed to investigate the possible effect of ISO on blood cell counts especially MPV and MPV/platelet ratio.

Materials and Methods

75 patients, between the ages of 18–25 with moderate or severe acne vulgaris and using oral isotretinoin (0.5 mg/kg) were included in the study. Platelet count and MPV values of patients (pre-treatment and 3 months after the treatment) were recorded retrospectively.

Results

The mean age of patients was 23.32±3.44 years. 40 patients were female and 35 were male. MPV levels and MPV/p ratio of “before treatment period” were significantly higher than the “after treatment period” (p<0.001).

Conclusion

In the literature, alteration in platelet levels under ISO treatment is a controversial issue. Furthermore, it was emphasized that, ISO treatment may be change platelet functions. In our study, MPV values and MPV/p ratio were decreased after ISO treatment. Our data indicates that, the thromboembolic risk of patients with acne vulgaris may reduce after ISO treatment.

Top

Keywords

Acne vulgaris, Isotretinoin, MPV, Platelet, Thromboembolism risk.

Top

 
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
751,141,790 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.